  See all
 |
Articles: Breast |
Prior Articles
Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan
Cancer Science, 02/16/10
XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: Evidence from 37,369 subjects
Breast Cancer Research and Treatment, 02/16/10 Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: Results from the breast cancer family registry
Breast Cancer Research and Treatment, 02/15/10 The role of socioeconomic status in adjustment after ductal carcinoma in situ
Cancer, 02/15/10 Role of Mdm4 in drug sensitivity of breast cancer cells
Oncogene, 02/15/10 Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
Breast Cancer Research and Treatment, 02/15/10 Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
Breast Cancer Research and Treatment, 02/15/10 Tai chi for breast cancer patients: a systematic review
Breast Cancer Research and Treatment, 02/15/10 Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study
Breast Cancer Research and Treatment, 02/15/10 Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls
Breast Cancer Research and Treatment, 02/15/10 Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
Breast Cancer Research and Treatment, 02/15/10 Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene
Breast Cancer Research and Treatment, 02/15/10 Chromosome 17 Polysomy without Human Epidermal Growth Factor Receptor 2 Amplification Does Not Predict Response to Lapatinib Plus Paclitaxel Compared with Paclitaxel in Metastatic Breast Cancer
Clinical Cancer Research, 02/15/10 Low-Molecular-Weight Cyclin E Can Bypass Letrozole-Induced G1 Arrest in Human Breast Cancer Cells and Tumors
Clinical Cancer Research, 02/15/10 The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer
Clinical Cancer Research, 02/15/10
Exclusive Author Commentary Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort
International Journal of Cancer, 02/15/10 X-linked ectodermal dysplasia receptor is downregulated in breast cancer via promoter methylation
Clinical Cancer Research, 02/12/10 Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: A negative phase II and screening of potential therapeutic markers by proteomic analysis
Clinical Cancer Research, 02/12/10 The influence of cosmetic breast augmentation on the stage distribution and prognosis of women subsequently diagnosed with breast cancer
International Journal of Cancer, 02/12/10 Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome
Modern Pathology, 02/12/10
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
125 Available Pages
|
|
